Table 2.
SYNJ1 in cellular and murine models of Alzheimer’s disease.
| Populations | Cellular and Murine Models
|
||
|---|---|---|---|
|
| |||
| Model and Treatment | Phenotype | Proposed Mechanism | |
|
| |||
| Late Onset AD (LOAD) | Human APOE4/4 knock-in (KI) mouse models |
SYNJ1 levels unchanged, compared to ApoE null (knock-out) mice [64] SYNJ1 mRNA levels and SYNJ1 protein levels increased, compared to APOE3/3 KI mouse models [64] miR-195 levels reduced, compared to APOE3/3 KI mice [69] |
Genetically decreasing SYNJ1 levels in ApoE4 KI mice rescues the cognitive deficits exhibited by these mice [64] |
| Primary cultures of hippocampal ApoE null neurons | Incubation with conditioned media derived from APOE3/3 astrocytes, but not ApoE4/4 or ApoE null astrocytes, leads to a reduction of SYNJ1 levels [64] | Accelerated degradation of SYNJ1 mRNA [64] | |
| Incubation with conditioned media derived from ApoE4/4 astrocytes leads to lower miR-195 levels, compared to APOE3/3 astrocytes [69] | Upregulation of miR-195 can modulate SYNJ1 expression, supported by the fact that overexpressing miR-195 reduces SYNJ1 protein levels in ApoE null, APOE3/3 and ApoE4/4 neurons [69] | ||
| Human ApoE4/4 knock-in (KI) mouse models with or without a transgenic AD background, viral delivery of miR-195 in the hippocampus | Rescue of cognitive deficits and reduction of tau hyper-phosphorylation [69]. Reduction in Aβ42 oligomers and amyloid plaque burden in the transgenic AD background [69] | ||
| Human iPSCs-derived neurons and astrocytes co-cultures from an ApoE4/4 LOAD patient or an APOE3/3 control. | Enlargement of lysosomes in human ApoE4/4 neurons [69] | Over-expression of miR-195 reduces lysosomal enlargement and reduces phosphorylated tau levels in human ApoE4/4 neurons [69] | |
| SYNJ1+/+ and SYNJ1−/− neurons co-cultured with ApoE4/4 iPSC-derived astrocytes | Reduction of lysosomal size in SYNJ1−/− neurons compared to SYNJ1+/+ neurons [69] | miR-195 acts through the control of SYNJ1 levels on lysosomal homeostasis, supported by no additional effect of over-expression of miR-195 on lysosomal size in SYNJ1−/− neurons [69] | |
| Tg(SYNJ1) [70], compared to WT littermates | Increased levels of SYNJ1 [52,70] | ||
| Early endosomes enlargement [71] | |||
| 3-4-month-old: no deficit in the Morris water maze, deficit in the reverse platform test [70] | No differences in basal neurotransmission and synaptic plasticity [70] | ||
| 9-month-old: no deficit in the radial arm water maze (RAWM) and fear conditioning (FC) paradigms [52] | |||
| 19-month-old: deficit in the RAWM and decreased freezing in contextual FC [52] | Unchanged levels of pre-and post-synaptic proteins, but acute hyperexcitability and defect in the spatial reproducibility of hippocampal place fields [52] | ||
|
| |||
| High risk Down Syndrome (Ds) | Ts65Dn mouse model | Increased levels of SYNJ1, PtdIns(4,5)P2 reduction [70] | Restoring SYNJ1 copy number rescues PtdIns(4,5)P2 levels [70] |
| Lymphoblastoid cell lines derived from individuals with DS | Increased levels of SYNJ1, enlarged early endosomes [71] | The Hsa21 segment containing SYNJ1 is sufficient to induce early endosomal enlargement [71] | |
| Fibroblasts derived from individuals with DS | Increased levels of SYNJ1, enlarged early endosomes [71] | Decreasing SYNJ1 levels reduces the percentage of larger endosomes [71] | |
| Overexpression of SYNJ1 in SH-SY5Y neuroblastoma cell lines | Enlarged early endosomes [71] | ||
| Human iPSCs-derived neurons from individuals with DS and their euploid isogenic controls [73] | Increased levels of SYNJ1, higher secreted Aβ peptides, higher phosphorylated tau, impaired lysosomal transport, increased synaptic vesicle release [73] | Restoring SYNJ1 copy number to disomy did not rescue Aβ peptide secretion or tau phosphorylation, but restoring APP copy number did [73] | |
|
| |||
| High risk Autosomal Dominant AD (ADAD) | PSEN1 and PSEN2 ADAD cells | PtdIns(4,5)P2 reduction, Aβ42 increase [74] | Similarities with the overexpression of the inositol 5-phosphatase domain of SYNJ1 [74] |
| Genetic decrease of SYNJ1 in ADAD mouse models | Improvement of learning and memory deficits [75, 76] | Protection against the effect of Aβ oligomers on PtdIns(4,5)P2 decrease, long-term potentiation (LTP) impairment and synaptic toxicity [75, 77] Increased Aβ uptake and degradation [76] |
|
Abbreviations: miR, microRNA, iPSCs, induced pluripotent stem ceils, WT, wild-type.
Icons were generated by biorender.com.